Palle Christophersen
Founder at SANA AB
Net worth: 145 021 $ as of 2024-04-29
Network origin in Palle Christophersen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
22
| Public Company | Biotechnology | 22 |
| Public Company | Trucking | 21 | |
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders.
7
| Subsidiary | Miscellaneous Commercial Services | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Palle Christophersen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chairman Chairman | |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member | |
| I M SKAUGEN SE | Marine Shipping | Founder | |
| HARBOES BRYGGERI A/S | Beverages: Alcoholic | Director/Board Member | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| ALK-ABELLÓ A/S | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
CMC
 CMC Miscellaneous Commercial ServicesCommercial Services Part of Universal Music Group NV, CMC is a Danish company that publishes music records. The company is located in Denmark. CMC was acquired by EMI Group Ltd., part of Universal Music Group NV from June 29, 2012 on November 01, 1997. | Miscellaneous Commercial Services | Director/Board Member | |
Ferrosan ApS
 Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal | |
Azign Bioscience AS
 Azign Bioscience AS BiotechnologyHealth Technology Part of Atonomics A/S, Azign Bioscience AS is a biotechnology company based in Copenhagen, Denmark. The Danish company provides biotechnology services. Azign Bioscience was acquired by Atonomics A/S from NTG Nordic Transport Group A/S on June 30, 2004. | Biotechnology | Director/Board Member Chairman | |
| University of London | College/University | Graduate Degree | |
| University of Aarhus | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Symbion A/S
 Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | General Government | Director/Board Member Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| Technical University of Denmark | College/University | Graduate Degree | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Chairman | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | President Chief Tech/Sci/R&D Officer | |
| University of Southern Denmark | College/University | Graduate Degree Doctorate Degree | |
7TM A/S
 7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
Sophion Bioscience A/S
 Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Medical Specialties | Chairman Corporate Officer/Principal Chairman Chairman Director/Board Member | |
MedArt A/S
 MedArt A/S Medical SpecialtiesHealth Technology MedArt A/S aim to be your preferred partner within laser based treatments for surgical and aesthetic applications. More than 25 years of experience in the manufacturing of super compact, high performance diode and C02 lasers combined with scanning technology have provided doctors and clinics world-wide with high-performance equipment for strong patient satisfaction. Their unique combination of clinical understanding and proprietary technology has formed the background of their company and the MedArt® brand-medical art based on scientific research. | Medical Specialties | Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Founder Founder | |
Bok Holding A/S
 Bok Holding A/S BiotechnologyHealth Technology Bok Holding A/S is a holding company that operates as a biotechnology company that researches and develops cancer treatment solutions. It develops the ZAS platform technology which efficiently enhances the effect of current anti-cancer drugs and reduces toxicity. The firm employs molecular techniques commonly known as molecular breeding or directed enzyme evolution which can activate anti-cancer drugs. The company was founded by Zoran Gojkovic on November 22, 2001 and is headquartered in Gentofte, Denmark. | Biotechnology | Director/Board Member Director/Board Member Chairman Chairman | |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Director/Board Member | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Director/Board Member | |
| Statens Serum Institute | College/University | Director/Board Member | |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
Origio A/S
 Origio A/S BiotechnologyHealth Technology ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark. | Biotechnology | Director/Board Member Chairman | |
| Poseidon Pharmaceuticals A/S | Director/Board Member Chairman | ||
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Sentinext Therapeutics Sdn. Bhd. develops vaccines and therapeutics for tropical infectious diseases. Its pharmaceutical research and development focuses on EV71, polio, influenza and dengue diseases. The company was founded by Mary Jane Cardosa and Peter Samuel Wulff in 2009 and is headquartered in Penang, Malaysia. | Biotechnology | Founder | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| SPAGO NANOMEDICAL AB | Biotechnology | Director/Board Member Director/Board Member | |
Lundbeckfonden Ventures
 Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark. | Investment Managers | Private Equity Investor | |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Contera Pharma ApS
 Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Aniona ApS
 Aniona ApS Medical/Nursing ServicesHealth Services Aniona ApS is a private company based in Ballerup, Denmark. Jørgen Drejer has been the CEOs since incorporation. The Danish company was founded by Thomas Feldthus, Anker Gunvald Lundemose, Claus Tycho Bræstrup, Jørgen Drejer. | Medical/Nursing Services | Founder Founder Founder Founder Director/Board Member | |
iSD Immunotech ApS
 iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Biotechnology | Founder | |
| INITIATOR PHARMA A/S | Pharmaceuticals: Major | Founder Founder | |
Sementis Ltd.
 Sementis Ltd. BiotechnologyHealth Technology Sementis Ltd. is an Australian private company that develops next-generation vaccine viral-vector software platform. | Biotechnology | Director/Board Member | |
Synklino A/S
 Synklino A/S BiotechnologyHealth Technology Synklino A/S develops a CMV-specific immunotoxin that aims to eliminate cytomegalovirus infections. | Biotechnology | Director/Board Member |
Statistics
International
| Denmark | 39 |
| United States | 4 |
| Sweden | 4 |
| United Kingdom | 3 |
| Norway | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Finance | 4 |
| Transportation | 2 |
Operational
| Director/Board Member | 219 |
| Corporate Officer/Principal | 90 |
| Chairman | 63 |
| Chief Executive Officer | 50 |
| Independent Dir/Board Member | 49 |
Most connected contacts
| Insiders | |
|---|---|
| Mette Agger | 30 |
| Joseph deBethizy | 29 |
| Patrik Olof Dahlén | 28 |
| Claus Tycho Bræstrup | 27 |
| Torbjørn Bjerke | 27 |
| Jørgen Drejer | 26 |
| Anker Gunvald Lundemose | 25 |
| Flemming Heise Pedersen | 24 |
| Robert Hoffman | 22 |
| Thomas Hofman-Bang | 22 |
| Carl Johan Bertil Sundberg | 21 |
| Thomas Feldthus | 20 |
| Sven Anders Ullman | 19 |
| Jørgen Buus Lassen | 15 |
| Peter Samuel Wulff | 12 |
- Stock Market
- Insiders
- Palle Christophersen
- Company connections
